{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:19:23Z","timestamp":1782296363674,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":6554,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jpain.2005.05.005","type":"journal-article","created":{"date-parts":[[2005,10,2]],"date-time":"2005-10-02T07:07:49Z","timestamp":1128236869000},"page":"704-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Use of Oxcarbazepine to Treat a Pediatric Patient With Resistant Complex Regional Pain Syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"Kirk","family":"Lalwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence","family":"McGraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.jpain.2005.05.005_bib1","first-page":"S14","article-title":"Use of anticonvulsants for treatment of neuropathic pain","volume":"59","author":"Backonja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2005.05.005_bib2","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2005.05.005_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000542-200502000-00003","article-title":"Complex regional pain syndromes in children and adolescents","volume":"102","author":"Berde","year":"2005","journal-title":"Anesthesiology"},{"issue":"pt 2","key":"10.1016\/j.jpain.2005.05.005_bib4","first-page":"152S","article-title":"Safety and efficacy of oxcarbazepine","volume":"20","author":"Beydoun","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpain.2005.05.005_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00002508-200405000-00007","article-title":"Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy","volume":"20","author":"Beydoun","year":"2004","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2005.05.005_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(95)00516-1","article-title":"Carbamazepine exerts anti-inflammatory effects in the rat","volume":"294","author":"Bianchi","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"suppl","key":"10.1016\/j.jpain.2005.05.005_bib7","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(03)00067-8","article-title":"Rationale and evidence for the use of oxcarbazepine in neuropathic pain","volume":"25","author":"Carrazana","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2005.05.005_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00002508-200207000-00002","article-title":"Defining the therapeutic role of local anesthetic sympathetic blockade in complex regional pain syndrome","volume":"18","author":"Cepeda","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2005.05.005_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00000542-200502000-00022","article-title":"Continuous peripheral nerve blocks at home for treatment of recurrent complex regional pain syndrome I in children","volume":"102","author":"Dadure","year":"2005","journal-title":"Anesthesiology"},{"issue":"suppl A","key":"10.1016\/j.jpain.2005.05.005_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/eujp.2001.0323","article-title":"Neurobiology of neuropathic pain","volume":"6","author":"Dickenson","year":"2002","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2005.05.005_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0304-3959(03)00253-7","article-title":"Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea pig","volume":"105","author":"Fox","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2005.05.005_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(01)01007-X","article-title":"Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers","volume":"420","author":"Ichikawa","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"suppl A","key":"10.1016\/j.jpain.2005.05.005_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain","volume":"6","author":"Jensen","year":"2002","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2005.05.005_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1440-1681.2004.03950.x","article-title":"Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy","volume":"31","author":"Kiguchi","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"suppl 3","key":"10.1016\/j.jpain.2005.05.005_bib15","first-page":"S5","article-title":"Oxcarbazepine","volume":"35","author":"McLean","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpain.2005.05.005_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0885-3924(01)00282-2","article-title":"Treatment of reflex sympathetic dystrophy (CRPS type 1)","volume":"21","author":"Perez","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2005.05.005_bib17","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of post herpetic neuralgia","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2005.05.005_bib18","series-title":"An open-label trial of oxcarbazepine in patients with complex regional pain syndrome refractory to gabapentin","author":"Royal","year":"2002"},{"key":"10.1016\/j.jpain.2005.05.005_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00002508-199909000-00009","article-title":"Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy","volume":"15","author":"Sherry","year":"1999","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2005.05.005_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0889-8537(03)00084-1","article-title":"Complex regional pain syndrome","volume":"21","author":"Stanton-Hicks","year":"2003","journal-title":"Anesthesiol Clin North Am"},{"key":"10.1016\/j.jpain.2005.05.005_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00002508-199806000-00012","article-title":"Complex regional pain syndromes","volume":"14","author":"Stanton-Hicks","year":"1998","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2005.05.005_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1528-1157.1995.tb00958.x","article-title":"Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents","volume":"36","author":"Stefani","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpain.2005.05.005_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0920-1211(00)00201-1","article-title":"The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons","volume":"43","author":"Stefani","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jpain.2005.05.005_bib24","series-title":"An open-label trial of oxcarbazepine in patients with radiculopathy refractory to gabapentin","author":"Ward","year":"2002"},{"key":"10.1016\/j.jpain.2005.05.005_bib25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2106\/00004623-199274060-00013","article-title":"Reflex sympathetic dystrophy in children","volume":"74","author":"Wilder","year":"1992","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jpain.2005.05.005_bib26","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U","article-title":"Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures","volume":"42","author":"Yaron","year":"1999","journal-title":"Arthritis Rheum"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590005007133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590005007133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:41:40Z","timestamp":1761507700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590005007133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1526590005007133"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2005.05.005","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Oxcarbazepine to Treat a Pediatric Patient With Resistant Complex Regional Pain Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2005.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}